You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 9,789,257


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,789,257
Title:Needle assisted injection device having reduced trigger force
Abstract: An injector includes a trigger mechanism including: a trigger member disposed about an axis having an aperture and a protrusion, and a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a trigger engagement member configured to engage the aperture of the trigger member when the trigger member is in a pre-firing condition; an energy source associated with the ram for powering the ram to expel the medicament; and a user-operable firing-initiation member having an aperture engaged with the protrusion of the trigger member and operable for causing an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
Inventor(s): Travanty; Michael (S. Minneapolis, MN)
Assignee: Antares Pharma, Inc. (Ewing, NJ)
Application Number:15/418,659
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,789,257
Patent Claims: 1. An injector, comprising: a container containing progesterone or a derivative thereof; a trigger mechanism including: a trigger member disposed about an axis, the trigger member having a trigger member opening wall and a trigger member protrusion, and a ram assembly having a ram configured to pressurize the container for expelling the progesterone or derivative thereof from the container, the ram assembly further having a trigger engagement member configured to engage the trigger member opening wall when the trigger member is in a pre-firing condition; an energy source associated with the ram and configured to power the ram to expel the progesterone or derivative thereof; and a guard including a guard aperture receiving the trigger member protrusion, the guard configured to cause an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is disengaged from the trigger member opening wall to allow the energy source to fire the ram.

2. The injector of claim 1, wherein the guard aperture slidingly receives the trigger member protrusion.

3. The injector of claim 1, wherein the injector is configured to inject at least about 0.5 ml of the progesterone or derivative thereof in less than about 14 seconds.

4. The injector of claim 1, wherein the energy source is configured to pressurize the progesterone or derivative thereof to a pressure within a range of about 90 p.s.i. to about 600 p.s.i.

5. The injector of claim 1, further comprising: an injector housing, wherein the guard includes a skin-contacting portion disposed at a distal end of the injector, the skin-contacting portion being movable proximally with respect to the housing when a force is applied to the skin-contacting portion at the distal end of the injector, the guard being associated with the trigger member and configured to cause the axial translation of the trigger member in a proximal direction from the pre-firing condition to the firing condition upon a proximal movement of the skin-contacting portion with respect to housing.

6. The injector of claim 5, wherein the skin-contacting portion is coupled to the guard, the guard being configured to expose a needle connected to the container upon the proximal movement of the skin-contacting portion.

7. The injector of claim 6, further comprising a needle in fluid communication with the container for injecting the progesterone or derivative thereof expelled therefrom when the ram is fired.

8. The injector of claim 7, wherein the energy source and needle are configured for injecting the progesterone or derivative thereof at an average velocity of at least about 1,000 cm/sec within the needle.

9. The injector of claim 1, further comprising a ram holding member that engages the trigger engagement member to axially retain the ram assembly in a proximal position against action of the energy source in the pre-firing condition.

10. The injector of claim 9, wherein in the firing condition the ram assembly is disengaged from the trigger member opening wall, and the energy source overcomes the engagement between the trigger engagement member and the ram holding member.

11. The injector of claim 9, wherein the ram holding member includes a projection that includes a bulge and a groove that are configured to engaged the trigger engagement member, and the trigger member opening wall retains the engagement of the trigger engagement member with the bulge and groove in the pre-firing condition.

12. The injector of claim 9, further comprising a latch retention angle defined by the axis and a contact surface of the ram holding member and the trigger engagement member.

13. The injector of claim 12, wherein the latch retention angle is between about 35.degree. and about 45.degree..

14. The injector of claim 12, wherein the latch retention angle is between about 75.degree. and about 85.degree..

15. An injector, comprising: a container containing progesterone or an analogue of progesterone; a trigger mechanism including: a trigger member disposed about an axis, the trigger member having a trigger member opening wall and a trigger member protrusion, and a ram assembly having a ram configured to pressurize the container for expelling the progesterone or analogue of progesterone from the container, the ram assembly further having a trigger engagement member configured to engage the trigger member opening wall when the trigger member is in a pre-firing condition; an energy source associated with the ram and configured to power the ram to expel the progesterone or analogue of progesterone; and a user-operable guard including a guard aperture receiving with the trigger member protrusion, the user-operable guard configured to cause an axial translation of the trigger member in a proximal direction from the pre-firing condition to a firing condition in which the trigger engagement member is disengaged from the trigger member opening wall to allow the energy source to fire the ram, wherein the energy source expels the analogue of progesterone at a stream velocity of at least about 100 centimeters per second.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.